Considerations for the Safe and Effective Use of Iron Interventions in Areas of High Malaria Burden (U01)

The summary for the Considerations for the Safe and Effective Use of Iron Interventions in Areas of High Malaria Burden (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Considerations for the Safe and Effective Use of Iron Interventions in Areas of High Malaria Burden (U01): -Purpose. The goal of this FOA is to develop new knowledge to support the development of an evidence-based program to improve global policy and guide the implementation of programs designed to prevent and treat iron deficiency disorders. Through the solicitation of high quality applications this FOA is intended to address those factors affecting the safe and effective use of iron interventions for the prevention and treatment of iron deficiency and anemia in women of reproductive age (including adolescent girls), infants, and children, particularly in areas of endemic malaria. Priority research questions related to the interaction of iron and malaria have been identified through direct engagement of the global health community, and agencies responsible for setting policy and implementing nutrition and malaria control programs, as well as scientists from relevant disciplines impacting on this issue. -This FOA will solicit applications in three core priority areas: 1) mechanisms: what are the key mechanisms by which iron status and interventions that may impact on that status can influence host immunity and response to malaria and other infections? 2) biomarkers: what are the most suitable indicators of iron status that can be used particularly, but not limited to, in resource limited settings and how do these relate to disease outcome?, and 3) interventions: what are the safest and most effective interventions to prevent and treat iron deficiency in women, infants and children in areas of endemic malaria?

Federal Grant Title:	Considerations for the Safe and Effective Use of Iron Interventions in Areas of High Malaria Burden (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Income Security and Social Services Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HD-08-028
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.865
CFDA Descriptions:	Child Health and Human Development Extramural Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Sep 09, 2008
Posted Date:	Jul 10, 2008
Creation Date:	Jul 10, 2008
Archive Date:	Oct 10, 2008
Total Program Funding:	$1,860,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Others (see text field entitled "Additional Information on Eligibility" for clarification) County governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Independent school districts Small businesses Private institutions of higher education For profit organizations other than small businesses Special district governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional...; • Early Immune System Development and Ontogeny (R01 Clinical Trial Optional); • Rehabilitation Research Career Development Programs (K12 Clinical Trial Optional); • Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - ...; • Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - ...; • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...; • Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health: • NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional); • Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and ...; • NIGMS Institutional Biomedical Undergraduate Research Training (BURT) Program (T34); • Limited Competition: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic ...; • Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional)